Brind.

Neuronetics announced a collaboration agreement with Compass, leading to the FDA clearance of Spravato and the acquisition of Greenbrook TMS.

1 report, 1 independent Updated Jul 20

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Benzinga Compass FDA

Keep exploring

The entities involved

Benzinga
American news channel
- Morgan Stanley and Citigroup are providing stock research and analysis on Appian, with Benzinga reporting on the coverage.Fri 23:47
- MarketBeat provided consensus rating data and Benzinga reported analyst price objective changes for Prestige Consumer Healthcare.Fri 21:24
Compass
Credit institution that offers online loans, personal financing, and other financial products.
- Compass acquired Anywhere Real Estate, which prompted an antitrust investigation by the New York Attorney General.Fri 18:35
- Local real estate firms are competing with Compass in the market.Wed 00:17
FDA
- The FDA approved Miplyffa for the treatment of Niemann-Pick disease.Sat 00:55
- iRhythm Technologies launched its Zio ECG system in Japan following FDA clearance, amid reports that Trump-era tariffs benefit AI stocks.Fri 23:50

Related events

Coverage

Newest first; wire copies grouped

Jul 20benzinga.com